Predictors of prolonged hypotension requiring vasopressor support after resection of pheochromocytoma and paraganglioma

Clin Endocrinol (Oxf). 2021 Dec;95(6):841-848. doi: 10.1111/cen.14542. Epub 2021 Jul 12.

Abstract

Objective: Prolonged hypotension is a common complication after resection of pheochromocytoma (PCC) or paraganglioma (PGL). The objective of our study was to identify preoperative or intraoperative clinical factors that can predict prolonged hypotension after PCC/PGL resection.

Patients and methods: A total of 414 patients who underwent resection of PCC or PGL at our institution between January 2013 and January 2020 were included. Patients were divided into two groups according to whether or not vasopressor support was required postoperatively. Associations between preoperative and intraoperative variables and prolonged hypotension were evaluated.

Results: Two hundred and one (48.6%) patients had postoperative hypotension that required vasopressor support with a median duration of 20 h. Multivariable analysis demonstrated that increased 24-h urinary norepinephrine (NE) levels (odds ratio [OR] = 1.091, 95% confidence interval [CI]: 1.052-1.132, p < .001), longer operative time (OR = 1.008, CI: 1.004-1.011, p < .001) and lower preoperative phenoxybenzamine dose (OR = 0.336, CI: 0.150-0.753, p = .008) were predictors of prolonged hypotension. Moreover, operative time, body mass index, 24-h urinary level of NE and preoperative phenoxybenzamine dose were significantly correlated with the duration of postoperative vasopressor support.

Conclusions: Increased urine NE level, longer operative time and lower preoperative phenoxybenzamine dose were predictors of prolonged hypotension requiring vasopressor support. Clinicians can identify these factors to manage their patients better and prevent severe complications.

Keywords: paraganglioma; pheochromocytoma; predicting factors; prolonged hypotension.

MeSH terms

  • Adrenal Gland Neoplasms* / surgery
  • Humans
  • Hypotension* / drug therapy
  • Hypotension* / etiology
  • Paraganglioma* / drug therapy
  • Paraganglioma* / surgery
  • Pheochromocytoma* / surgery
  • Retrospective Studies